Back

Bernstein maintains Buy rating on Boston Scientific with $54 price target

Verifying
  • Bernstein maintained a Buy rating and $54 price target for Boston Scientific.
  • Boston Scientific reported $5.44 billion in quarterly revenue and $907 million net profit.
  • Wells Fargo assigned BSX a Hold rating on September 24, while RBC Capital issued a Buy.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.